Clinical Trials
Sanofi and GSK initiate new Phase 2 study of...
Sanofi and GSK announced the initiation of a new Phase 2 study with 720 volunteers aged 18 and over to select the most appropriate antigen...
Clinical Trials
Parexel and NeoGenomics announce partnership to improve clinical trials
Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization, and NeoGenomics,...
Clinical Trials
Vaxart Announces Positive Preliminary Data from Phase 1 Clinical...
Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines administered by tablet, announced preliminary data from its Phase 1 study of VXA-CoV2-1 showing that its...
Clinical Trials
Oxford leads first trial investigating dosing with alternating vaccines
The University of Oxford is to lead the first trial to explore alternating different COVID-19 vaccines, to explore the potential for flexibility in delivery and...
Clinical Trials
Ampio Announces Early Positive Data in Phase 1 Trial...
Ampio Pharmaceuticals, Inc., a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, announced early positive data from its ongoing U.S....
Clinical Trials
Aizon Launches GxP AI Bioreactor Application for the Pharma...
Aizon launches its Bioreactor Application, the pharma industry’s first predictive analysis and deep knowledge management application. The Aizon Bioreactor Application adds the bioreactor process to...
Clinical Trials
Rigel Awarded $16.5 Million from U.S. Department of Defense...
Rigel Pharmaceuticals, Inc. announced it has been awarded $16.5 million by the U.S. Department of Defense's (DOD) Joint Program Executive Office for Chemical, Biological, Radiological...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.